Skip to content
Clinical Trials – home
Verifiedinfo

Praktyka Lekarska Małgorzata Wojtanowska-Bogacka

Poland Barwicka 14H/4, 60-192 Poznan, Poland

  • 2 trials recruiting
  • Major depression · Anhedonia · Cognitive disorder
  • Adult patients

About Specializations

Praktyka Lekarska Małgorzata Wojtanowska-Bogacka in Poznan, Poland specialises in clinical trials of conditions such as Major depression, Anhedonia, Cognitive disorder, Schizophrenia, and other specialisations. This site conducts important research.

Main research areas of the site

Major Depressive Disorder (MDD) Treatment

The medical center is at the forefront of research in Major Depressive Disorder (MDD), focusing on innovative adjunctive therapies to enhance treatment outcomes. The center's work in this area aims to improve the efficacy of existing antidepressant treatments by integrating new therapeutic agents.

  • Adjunctive therapy to antidepressants
  • Innovative treatment strategies
  • Improving patient outcomes

By exploring flexible dosing regimens and novel compounds, the center contributes significantly to the understanding and management of MDD, offering hope for patients with inadequate responses to standard treatments.

Cognitive Impairment in Schizophrenia

Specializing in the treatment of cognitive impairment associated with schizophrenia, the medical center is pioneering research into therapeutic interventions that target cognitive deficits. This research is crucial for enhancing the quality of life and functional outcomes for individuals with schizophrenia.

  • Schizophrenia-related cognitive disorders
  • Therapeutic interventions for cognitive enhancement
  • Improving cognitive performance

Through adaptive, randomized, and placebo-controlled studies, the center is advancing the field of cognitive disorder treatment, providing new insights into effective management strategies for schizophrenia.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Barwicka 14H/460-192 PoznanPoland
Recruiting now
2 trials
Conditions studied
4
Partner status
Verified

More sites in PoznanPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:SELTOREXANT
  • Sponsor:Janssen - Cilag International
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Major depression

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International

Cognitive disorder+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.